| 摘要: |
| 目的 研究苦参碱自微乳新型制剂在抗肿瘤方面的作用。方法 制备自微乳、原料药含药血清,噻唑蓝(MTT)法和流式细胞仪测定其对肝癌HepG2细胞增殖、凋亡、周期的影响。结果 干预24 h,20%、30%自微乳组与20%、30%原料药组的抑制率分别为25.63%、57.63%、12.10%、32.18%;作用48 h,20%、30%自微乳含药血清的抑制率为27.81%、63.68%,20%、30%原料药含药血清的抑制率为18.42%、44.97%。用20%、30%含药血清干预HepG2细胞时,自微乳组的凋亡率为47.53%、72.19%,S期所占比例为15.17%、19.1%;原料药组的凋亡率为31.97%、42.19%,S期所占比例为11.42%、13.11%。结论 苦参碱自微乳抗肿瘤活性显著。 |
| 关键词: 细胞增殖 凋亡 体外抗肿瘤 肝癌 |
| DOI:10.13506/j.cnki.jpr.2019.06.003 |
| 基金项目: |
|
|
|
| Study on antitumor activity of matrine microemulsion in vitro |
| GUO Mingxing1,SU Tingting2,FU Chunsheng3 |
| (1. Medical Management Service Center of Shandong Health Commission,Jinan 250014,China;2. Jinan Integrated Traditional Chinese and Western Medicine Hospital,Jinan 271100,China;3. Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250014,China) |
| Abstract: |
| Objective To study the anti-tumor effect of matrine self-emulsion.Methods We prepared matrine microemulsion containing serum and matrine containing drug serum.We used MTT assay and flow cytometry to compare the effects of different serum containing drugs on the proliferation, apoptosis and cycle of HepG2 cells.Results When the drug action 24 h,20%, 30% self-microemulsion serum were inhibited by 25.63%, 57.63%.20%,30% matrine serum were inhibited by 12.10%,32.18%.When the drug action 48 h,20%,30% self-microemulsion serum were inhibited by 27.81%,63.68%.20%,30% matrine serum were inhibited by 18.42%,44.97%. When HepG2 cells were treated with 20%,30% serum containing serum,the apoptosis rates of the self-microemulsion group were 47.53% and 72.19% respectively, and the proportion of S was about 15.17% and 19.1% respectively;the apoptosis rates of the matrine group were 31.97% and 42.19% respectively, and the proportion of S was about 11.42% and 13.11% respectively.Conclusion Matrine microemulsion has significant anti-tumor activity. |
| Key words: Cell proliferation Apoptosis Anti-tumor in vitro Liver cancer |